Revolution Medicines, Inc. - COM (RVMD)

Historical Portfolio Holders from Q1 2020 to Q3 2024

All holders as of September 30, 2024
Q3 2024
Type / Class
Equity / COM
Shares, excl. options Q3 2024
169M
Holdings value Q3 2024
$7.66B
Value change Q3 2024
+$1.51M
Grand Portfolio weight change Q3 2024
+0%
Number of holders
248
Number of buys Q3 2024
140
Number of sells Q3 2024
-83
Average buys Q3 2024 %
+0.001%
Average sells Q3 2024 %
-0.002%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 169M $7.66B +$1.51M $45.35 250
2024 Q2 168M $6.54B +$376M $38.81 221
2024 Q1 159M $5.12B -$12.1M $32.23 204
2023 Q4 160M $4.59B +$1.19B $28.68 187
2023 Q3 112M $3.1B +$1.62M $27.68 166
2023 Q2 112M $2.99B +$107M $26.75 139
2023 Q1 108M $2.34B +$421M $21.66 148
2022 Q4 88.2M $2.1B +$32.6M $23.82 131
2022 Q3 88.3M $1.74B +$234M $19.72 131
2022 Q2 76.4M $1.49B +$41M $19.49 124
2022 Q1 73.9M $1.89B +$15.8M $25.51 121
2021 Q4 73.3M $1.85B -$50.1M $25.17 112
2021 Q3 68.9M $1.9B +$49.8M $27.51 109
2021 Q2 70.3M $2.23B +$91.6M $31.74 126
2021 Q1 66.4M $3.05B +$424M $45.88 124
2020 Q4 57.4M $2.27B +$133M $39.59 117
2020 Q3 57M $1.98B +$340M $34.80 90
2020 Q2 46.9M $1.48B +$22.8M $31.57 73
2020 Q1 46.9M $1.03B +$1.02B $21.91 72